Company Description
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America.
It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments.
The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions.
It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products.
The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines.
The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients.
The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients.
The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products.
International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
Country | United States |
IPO Date | Dec 17, 1974 |
Industry | Chemicals - Specialty |
Sector | Basic Materials |
Employees | 21,500 |
CEO | Jon Erik Fyrwald |
Contact Details
Address: 521 West 57th Street New York, New York United States | |
Website | https://www.iff.com |
Stock Details
Ticker Symbol | IFF |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000051253 |
CUSIP Number | 459506101 |
ISIN Number | US4595061015 |
Employer ID | 13-1432060 |
SIC Code | 2860 |
Key Executives
Name | Position |
---|---|
Jon Erik Fyrwald | Chief Executive Officer & Director |
Vic Verma | Executive Vice President & Chief Information Officer |
Beril Yildiz | Senior Vice President, Corporate Controller & Chief Accounting Officer |
Deborah Borg | Executive Vice President and Chief Human Resources, Communications and Diversity, Equity & Inclusion Officer |
Dr. Jennifer Amy Johnson Ph.D. | Executive Vice President, General Counsel & Corporate Secretary |
Glenn Robert Richter | Executive Vice President and Chief Financial & Business Transformation Officer |
Michael DeVeau | Senior Vice President of Corporate Finance & Investor Relations |
Ralf Finzel Ph.D. | Executive Vice President & Global Operations Officer |
Simon Herriott | President of Health & Biosciences |
Yuvraj Arora | Executive Vice President & President of Nourish |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 10, 2024 | 8-K | Current Report |
Dec 03, 2024 | 4 | Filing |
Nov 12, 2024 | 4 | Filing |
Nov 05, 2024 | 10-Q | Quarterly Report |
Nov 05, 2024 | 8-K | Current Report |
Oct 18, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Oct 07, 2024 | 4 | Filing |
Oct 03, 2024 | 4 | Filing |
Sep 05, 2024 | 4 | Filing |
Aug 06, 2024 | 10-Q | Quarterly Report |